Tumour invasion and metastasis are promoted in mice deficient in tenascin-X

K Matsumoto1, N Takayama, J Ohnishi

  • 1Department of Molecular Biology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan. kematsum@pharm.hokudai.ac.jp

Abstract

Insights

Tenascin-X (TNX) deficiency in mice increased tumor invasion and metastasis. This was linked to higher matrix metalloproteinase (MMP) activity, suggesting TNX normally inhibits tumor spread.

Area of Science:

  • Extracellular Matrix Biology
  • Cancer Metastasis Research
  • Molecular Oncology

Background:

  • Tenascin-X (TNX) is an extracellular matrix glycoprotein.
  • Its role in tumor invasion and metastasis is not fully understood.

Purpose of the Study:

  • To investigate the role of TNX in tumor invasion and metastasis.
  • To elucidate the physiological function of TNX.

Main Methods:

  • Gene disruption of TNX in mouse embryonic stem cells.
  • Generation of TNX-null mutant (TNX-/-) mice.
  • Subcutaneous inoculation of B16-BL6 melanoma cells.
  • Analysis of tumor size, invasion, metastasis, and matrix metalloproteinase (MMP) activity.

Main Results:

  • TNX-/- mice showed significantly increased primary tumor size, invasion, and pulmonary metastasis compared to wild-type mice.
  • Elevated activities of proMMP-2, active MMP-2, and proMMP-9 were observed in TNX-/- mice.
  • Increased MMP-2 activity was due to transcriptional upregulation, leading to decreased laminin levels.

Conclusions:

  • TNX deficiency enhances tumor invasion and metastasis.
  • Increased MMP production and activity in TNX-deficient mice contribute to tumor spread.
  • TNX plays a crucial role in inhibiting tumor cell invasion and metastasis.